The fish was initially recalled in October due to laboratory testing confirming Listeria monocytogenes on Oct. 21, 2024, ...
The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.
The recall affects 12-ounce bags of the product, which were sold in 20 states and pose serious health risks if consumed.
The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU ...